Prostperia

Develops artificial intelligence software that makes the interpretation of PSA - the world's most widely used prostate cancer screening test - more precise and personalised.
By combining laboratory results with patient characteristics, our solutions provide individualised prostate cancer risk assessment to support clinical decision-making, follow-up, and the use of further investigations.